LA
MED icon

Lee Ainslie’s Medifast MED Stock Holding History

Lee Ainslie’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,750
Closed -$495K – 736
2021
Q2 		$495K Sell
1,750
-3,490
-67% -$946K ﹤0.01% 392
2021
Q1 		$1.11M Sell
5,240
-1,536
-23% -$368K 0.01% 232
2020
Q4 		$1.33M Sell
6,776
-1,905
-22% -$337K 0.02% 191
2020
Q3 		$1.43M Buy
8,681
+3,084
+55% +$508K 0.03% 195
2020
Q2 		$777K Buy
+5,597
New +$514K 0.02% 378
2018
Q2 		– Sell
-37,160
Closed -$3.47M – 273
2018
Q1 		$3.47M Buy
+37,160
New +$2.78M 0.04% 170

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lee Ainslie's MED Position: Q3 2021 in Review

Lee Ainslie sold out of Medifast (MED) in Q3 2021, closing a stake of 1,750 shares — an estimated $495K sold.

Lee Ainslie first reported a position in MED in Q1 2018 and held it in 6 quarters. The position peaked at $3.47M in Q1 2018. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • Lee Ainslie reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
  • Lee Ainslie sold 1,750 Medifast shares in Q3 2021, an estimated $495K.
  • Lee Ainslie first reported a position in Medifast in Q1 2018 and held it in 6 quarters.
  • Lee Ainslie's Medifast position peaked at $3.47M in Q1 2018.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Maverick Capital's 13F filing for Q3 2021, filed 15 Nov 2021.